0.93
-0.01(-1.06%)
Currency In USD
| Previous Close | 0.94 |
| Open | 0.99 |
| Day High | 0.99 |
| Day Low | 0.92 |
| 52-Week High | 2.2 |
| 52-Week Low | 0.92 |
| Volume | 27,845 |
| Average Volume | 39,031 |
| Market Cap | 27.98M |
| PE | -4.65 |
| EPS | -0.2 |
| Moving Average 50 Days | 1.1 |
| Moving Average 200 Days | 1.33 |
| Change | -0.01 |
If you invested $1000 in Dyadic International, Inc. (DYAI) 10 years ago, it would be worth $978.95 as of June 17, 2025 at a share price of $0.93. Whereas If you bought $1000 worth of Dyadic International, Inc. (DYAI) shares 5 years ago, it would be worth $108.77 as of June 17, 2025 at a share price of $0.93.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
GlobeNewswire Inc.
Jun 02, 2025 12:35 PM GMT
Rapid commercial validation has been achieved through key partnerships disrupting high value/high growth marketsLeadership team realigned in order to enable execution of ancillary protein strategyDyadic is well positioned to seize on geopolitical tai
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
GlobeNewswire Inc.
May 01, 2025 7:00 PM GMT
JUPITER, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and ani
Dyadic to Present at World Vaccine Congress | Washington
GlobeNewswire Inc.
Apr 16, 2025 6:00 PM GMT
JUPITER, Fla., April 16, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a biotechnology company that utilizes its microbial production platforms to develop commercial cell lines f